Balance Sheet Details - Schedule of Accrued Expenses (Details) - USD ($) |
Mar. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Schedule of Accrued Expenses [Abstract] | |||
| Accrued payroll and related expenses | $ 217,967 | $ 835,724 | $ 768,720 |
| Accrued clinical study expenses | 236,168 | 183,824 | 10,268 |
| Accrued professional fees | 67,049 | 219,888 | |
| Accrued clinical development costs | 41,203 | 153,584 | |
| Accrued other expenses | 9,497 | ||
| Total accrued expenses | $ 463,632 | $ 1,127,800 | $ 1,152,460 |
| X | ||||||||||
- Definition Accrued Clinical Development Costs No definition available.
|
| X | ||||||||||
- Definition Accrued Clinical Study Expenses No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|